Call for Poster Abstracts – HOPA Annual Conference 2023
HOPA’s 19th Annual Conference | March 29 – April 1, 2023 | Phoenix, AZ
HOPA invites you to submit your research abstracts to present in the following topics at our 19th Annual Conference.
Initial Abstract Submissions windows:
Please note the following submission dates:
• Call for Completed and Encore Research: open August 1-October 10, 2022
• Call for Late Breaking Research: EXTENDED! Now open November 1-December 11, 2022
• Call for Trainee Research: open November 14, 2022-January 8, 2023
Dates for ACCEPTED abstracts*:
*These dates are only for authors who have already submitted an abstract during the above deadlines, and have been notified by HOPA that their abstract has been accepted.
• Deadline to submit Trainee e-posters for Trainee Award consideration: February 15, 2023
• Deadline to submit all other accepted files (non-award): March 19, 2023
• HOPA Annual Conference: March 29 – April 1, 2023 | Phoenix, AZ
Abstracts submitted after deadline will not be considered.
HOPA will use the information provided in conference materials so please ensure that author names, credentials, and titles, are written accurately. Degrees and certifications provided will only be included in published material. Selected completed research abstracts will be published in the Journal of Hematology/Oncology Pharmacy (JHOP), HOPA's official peer-reviewed forum for oncology pharmacy practice.
Final posters for selected research abstracts are required to be submitted prior to the Annual Conference for viewing of attendees. The deadline for ePosters is set typically four to six weeks prior to the Annual Conference. Should an institution have restrictions on the use of data in an online forum, please contact HOPA Education, at This email address is being protected from spambots. You need JavaScript enabled to view it. for further instructions.
Click to expand the following instructions and disclaimers for submitting research abstract materials.
Authorship
Responsibility for Expenses
The HOPA Annual Conference gives hematology/oncology pharmacy professionals the opportunity to present their work within an atmosphere of support by peers and national leaders. Presenters must register for at least the day on which they are scheduled to present. Only those presenters (or representatives) committed to attending the conference may submit an abstract. Presenters are responsible for all expenses such as travel, hotel, and meeting registration fees.
Avoidance of Commercialism
All presentations must avoid commercialism. Presentations that constitute promotion and advertising (including the use of logos) will not be considered. If the cost of any presentation has been underwritten to any extent, a clear acknowledgment stating the support, identifying the source, and describing the methods for keeping the content unbiased should be included. Advertising material that in any way promotes the commercial interest of a particular company, enterprise, or the author(s) may not be distributed or displayed. Statements made in the presentation are the sole responsibility of the author and are not viewed as, or considered representative of, any formal position taken on any product, subject, issue or by HOPA.
Abstract Embargo Policy
HOPA's embargo policy states that coverage of research abstracts being presented at the Annual Conference is strictly prohibited until two weeks before the conference. Content that is previously published online, in advance of print publication, is still subject to HOPA's embargo policy.
Guidelines for accepted posters can be found here.
Research that has been studied, tested, and has results and conclusions available for presentation.
Incomplete at the deadline, but now is able to be presented with results and conclusions.
A student, resident, or fellow, must be the primary author of the abstract being submitted.